PTK2/FAK: a new predictive biomarker for response to radiotherapy in head and neck squamous cell carcinoma

Por de Ruiter, Emma J., Willems, Stefan M.
Publicado no Ann Transl Med (2016)

TGF-β: An emerging player in drug resistance

Por Brunen, Diede, Willems, Stefan M, Kellner, Udo, Midgley, Rachel, Simon, Iris, Bernards, René
Publicado em 2013

Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review

Por Swartz, Justin E, Pothen, Ajit J, Stegeman, Inge, Willems, Stefan M, Grolman, Wilko
Publicado no Cancer Med (2015)

Running GAGs: myxoid matrix in tumor pathology revisited: What’s in it for the pathologist?

Por Willems, Stefan M., Wiweger, Malgorzata, van Roggen, J. Frans Graadt, Hogendoorn, Pancras C. W.
Publicado em 2009

Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: A systematic review

Por van Kempen, Pauline MW, Noorlag, Rob, Braunius, Weibel W, Stegeman, Inge, Willems, Stefan M, Grolman, Wilko
Publicado em 2014

Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option

Por Willems, Stefan M, Schrage, Yvonne M, Bruijn, Inge H Briaire-de, Szuhai, Karoly, Hogendoorn, Pancras CW, Bovée, Judith VMG
Publicado em 2010

The diagnostic value of 11q13 amplification and protein expression in the detection of nodal metastasis from oral squamous cell carcinoma: a systematic review and meta-analysis

Por Noorlag, Rob, van Kempen, Pauline M. W., Stegeman, Inge, Koole, Ron, van Es, Robert J. J., Willems, Stefan M.
Publicado no Virchows Arch (2015)

Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer

Por van Ginkel, Joost H., de Leng, Wendy W.J., de Bree, Remco, van Es, Robert J.J., Willems, Stefan M.
Publicado no Oncotarget (2016)

Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review

Por Dohmen, Amy J. C., Swartz, Justin E., Van Den Brekel, Michiel W. M., Willems, Stefan M., Spijker, René, Neefjes, Jacques, Zuur, Charlotte L.
Publicado no Cancers (Basel) (2015)

Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma

Por Koole, Koos, van Kempen, Pauline M. W., Swartz, Justin E., Peeters, Ton, van Diest, Paul J., Koole, Ron, van Es, Robert J. J., Willems, Stefan M.
Publicado no Cancer Med (2015)

Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review

Por Ipenburg, Norbertus A., Koole, Koos, Liem, K. Seng, van Kempen, Pauline M. W., Koole, Ron, van Diest, Paul J., van Es, Robert J. J., Willems, Stefan M.
Publicado no Target Oncol (2015)

Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors

Por van Kempen, Pauline M. W., Noorlag, Rob, Swartz, Justin E., Bovenschen, Niels, Braunius, Weibel W., Vermeulen, Jeroen F., Van Cann, Ellen M., Grolman, Wilko, Willems, Stefan M.
Publicado no Cancer Immunol Immunother (2016)

Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma

Por van Kempen, Pauline M W, Noorlag, Rob, Braunius, Weibel W, Moelans, Cathy B, Rifi, Widad, Savola, Suvi, Koole, Ronald, Grolman, Wilko, van Es, Robert J J, Willems, Stefan M
Publicado no Cancer Med (2015)

Promoter hypermethylation using 24-gene array in early head and neck cancer: Better outcome in oral than in oropharyngeal cancer

Por Noorlag, Rob, van Kempen, Pauline MW, Moelans, Cathy B, de Jong, Rick, Blok, Laura ER, Koole, Ronald, Grolman, Wilko, van Diest, Paul J, van Es, Robert JJ, Willems, Stefan M
Publicado em 2014

HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation

Por van Kempen, Pauline M W, van Bockel, Liselotte, Braunius, Weibel W, Moelans, Cathy B, van Olst, Marina, de Jong, Rick, Stegeman, Inge, van Diest, Paul J, Grolman, Wilko, Willems, Stefan M
Publicado no Cancer Med (2014)

Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation

Por Groenendijk, Floris H, Mellema, Wouter W, van der Burg, Eline, Schut, Eva, Hauptmann, Michael, Horlings, Hugo M, Willems, Stefan M, van den Heuvel, Michel M, Jonkers, Jos, Smit, Egbert F, Bernards, René
Publicado no Int J Cancer (2015)

Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma

Por De Herdt, Maria J., Willems, Stefan M., van der Steen, Berdine, Noorlag, Rob, Verhoef, Esther I., van Leenders, Geert J.L.H., van Es, Robert J.J., Koljenović, Senada, de Jong, Robert J. Baatenburg, Looijenga, Leendert H.J.
Publicado no Oncotarget (2016)

FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma

Por Koole, Koos, Clausen, Martijn J. A. M., van Es, Robert J. J., van Kempen, Pauline M. W., Melchers, Lieuwe J., Koole, Ron, Langendijk, Johannes A., van Diest, Paul J., Roodenburg, Jan L. N., Schuuring, Ed, Willems, Stefan M.
Publicado no Mol Diagn Ther (2016)

Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix

Por Willems, Stefan M, Mohseny, Alex B, Balog, Crina, Sewrajsing, Raj, Briaire-de Bruijn, Inge H, Knijnenburg, Jeroen, Cleton-Jansen, Anne-Marie, Sciot, Raf, Fletcher, Christopher D M, Deelder, André M, Szuhai, Karoly, Hensbergen, Paul J, Hogendoorn, Pancras C W
Publicado no J Cell Mol Med (2009)

FGFR1, 2 and 3 protein overexpression and molecular aberrations of FGFR3 in early stage non‐small cell lung cancer

Por Theelen, Willemijn SME, Mittempergher, Lorenza, Willems, Stefan M, Bosma, Astrid J, Peters, Dennis DGC, van der Noort, Vincent, Japenga, Eva J, Peeters, Ton, Koole, Koos, Šuštić, Tonći, Blaauwgeers, JL, van Noesel, Carel J, Bernards, René, van den Heuvel, Michel M
Publicado no J Pathol Clin Res (2016)